Full-Time

Statistical Programmer 2/3

Permanent role

ClinChoice

ClinChoice

1,001-5,000 employees

Global CRO providing full-service clinical development

No salary listed

Remote in USA

Remote

Remote role; US residents only.

Category
Biology & Biotech (1)
Required Skills
SAS
R

Get referred to ClinChoice

Find people who can refer or advise you

Requirements
  • Bachelor’s or Master’s degree in Statistics, Biostatistics, Computer Science, or a related field
  • 3+ years of experience in statistical programming within the pharmaceutical/biotech industry
  • Hands-on experience with R programming in a clinical trial environment
  • Good understanding of R packages.
  • Good understanding of CDISC standards (SDTM, ADaM)
  • Strong knowledge of clinical trial data and regulatory requirements
Responsibilities
  • Develop, validate, and maintain statistical programs using SAS for the generation of Tables, Listings, and Figures (TLFs)
  • Perform data manipulation, analysis, and visualization using R/SAS and relevant packages
  • Collaborate with Biostatisticians and Data Management teams to support clinical study deliverables
  • Ensure compliance with regulatory standards and company SOPs
  • Conduct quality control (QC) and validation of programming outputs
  • Support submission activities and documentation as required
Desired Qualifications
  • Experience working in an FSP model or with global pharmaceutical clients
  • Exposure to submission activities (e.g., FDA/EMA)
  • Familiarity with SAS alongside R is a plus
  • Strong problem-solving and communication skills

ClinChoice provides outsourced clinical development services as a global CRO for pharmaceutical, biotechnology, medical device, and consumer health clients. It supports trials across the full lifecycle with services including clinical operations, biostatistics, data management, regulatory affairs, medical affairs, pharmacovigilance, and project management, and it offers project-based or Functional Service Provider (FSP) engagement models. The company differentiates itself through its scale and international reach (4,000+ professionals in 30+ countries) and a track record of 1,500+ full-service studies, aided by growth from mergers and acquisitions. Its goal is to help clients accelerate drug and device approvals by efficiently managing multinational trials and navigating complex regulatory environments throughout development and post-marketing.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Whitemarsh Township, Pennsylvania

Founded

1995

Get referred to ClinChoice

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Recent $150M Series E funding accelerates planned expansion into high-growth markets.
  • Strategic acquisitions of CROMSOURCE and CSI strengthen regional hubs and service depth.
  • Japan and India certifications enable talent attraction for specialized clinical roles.

What critics are saying

  • IQVIA's AI-driven analytics threaten mid-market biotech clients within 12–24 months.
  • PPD's 25% larger oncology capacity captures top-10 pharma clients by mid-2026.
  • FDA's 2026 AI data validation mandate exposes legacy systems; 15–25% client loss risk.

What makes ClinChoice unique

  • Global footprint across 30+ countries with 4,000+ professionals managing multinational trials.
  • Full-service capabilities spanning clinical ops, biostatistics, data management, and pharmacovigilance.
  • Experienced leadership: CEO John Balian from Johnson & Johnson and Pfizer.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

9%

1 year growth

9%

2 year growth

9%
PR Newswire
Jan 12th, 2024
ClinChoice Acquires CSI, Expanding its Global Footprint into Southeast Asia

/PRNewswire/ -- ClinChoice, a leading global Contract Research Organization (CRO), today announced expanding its global footprint with the acquisition of CSI...

TalentSource Life Sciences
Mar 20th, 2023
Outsourcing in Clinical Trials Southeast 2023 – TalentSource Life Sciences

On March 1 st, 2023 ClinChoice acquired CROMSOURCE, strengthening its global network and deepening its full-service capabilities.

AVCJ
Jul 6th, 2022
Legend Capital invests into ClinChoice Inc. in $150M

US and China-based clinical contract research organization (CRO) company ClinChoice has raised a USD 150m Series E round led by Legend Capital.

Endpoints News
Jul 5th, 2022
Fountain Medical Development Ltd receives financing of $150M in Series E funding round

ClinChoice, formerly Fountain Medical Development, has completed a $150 million Series E funding round, using the cash to continue its planned expansion.

Cardinal Health
Apr 13th, 2022
Cloudbyz, Inc. partnered with ClinChoice Inc. on Apr 13th 22'.

Cloudbyz, a fast-growing integrated clinical research and development solution provider with integrated capabilities, today announced a partnership with ClinChoice, a global full-service clinical CRO dedicated to offering high-quality one-stop service to biopharmaceutical, Vaccine, Medical Device, Cosmetics, Nutraceuticals, and Consumer Products clients.